Loading company…
Spectrumedics develops shock wave balloon devices and other tools for minimally invasive cardiac and vascular treatments.
Founded in 2019 and based in Shanghai, Spectrumedics develops devices for minimally invasive cardiac and vascular procedures, with research and development centers in Shanghai and Singapore. Its products include Sonico-CX and Sonico-PX shock wave balloons for calcified coronary and peripheral artery lesions, along with intravascular shock wave therapy equipment. The company closed a Series B round in August 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in